Healthcare sector team

Analysts

Dr Nathaniel Calloway

Dr Nathaniel Calloway
Associate Healthcare Analyst

Lala Gregorek

Lala Gregorek
Director of Healthcare Research and Strategy

Pooya Hemami

Pooya Hemami
Analyst

Dr Dennis Hulme

Dr Dennis Hulme
Analyst

Maxim Jacobs

Maxim Jacobs
Director of Healthcare Research, North America

Dr Susie Jana

Dr Susie Jana
Analyst

Dr Jonas Peciulis

Dr Jonas Peciulis
Analyst

Dr Linda Pomeroy

Dr Linda Pomeroy
Analyst

Dr John Savin

Dr John Savin
Analyst

Juan Pedro Serrate

Juan Pedro Serrate
Associate Analyst

Dr Daniel Wilkinson

Dr Daniel Wilkinson
Analyst

By region

Recent initiations

MagForce Arix Bioscience
Formycon Collplant Holdings
Nuevolution Xbrane Biopharma

Recent QuickViews

Rovi

Enoxaparin biosimilars - natural evolution

Pharmaceutical & healthcare | published 15/06/2017
Therapix Bioscience

Cannabinoids for underserved diseases

Pharmaceutical & healthcare | published 07/06/2017
aap Implantate

Solid start to 2017

Pharmaceutical & healthcare | published 18/05/2017
Smith & Nephew

Continuing to focus on execution

Pharmaceutical & healthcare | published 10/05/2017

Would you like to be notified when new research is published? Access our research RSS feed

Latest research

Quantum Genomics

QGC001 clinical results

Update | Pharmaceutical & healthcare | 27/06/2017

Quantum Genomics announced the results from the 34-patient Phase IIa study of QGC001 for the treatment of mild to moderate arterial hypertension. It showed…

Prima BioMed

Preliminary LAG-3 combo data in breast cancer

Update | Pharmaceutical & healthcare | 23/06/2017

Preliminary efficacy data, which Prima BioMed presented at ASCO from the 15-patient, safety run-in phase of its AIPAC study, showed sustained immune activation…

Tonix Pharmaceuticals

Termination of coverage

Update | Pharmaceutical & healthcare | 22/06/2017

Edison Investment Research is terminating coverage on Tonix Pharmaceuticals (TNXP). Please note you should no longer rely on any previous research or estimates…

TiGenix

Termination of coverage

Update | Pharmaceutical & healthcare | 22/06/2017

Edison Investment Research is terminating coverage on Tigenix (TIGB). Please note you should no longer rely on any previous research or estimates for this…

Nexstim

Termination of coverage

Update | Pharmaceutical & healthcare | 22/06/2017

Edison Investment Research is terminating coverage on Nexstim (NXTMH). Please note you should no longer rely on any previous research or estimates for…

Sector commentary

See more reports See more reports See more reports

Sector reports

See more sector reports See more sector reports See more sector reports

Sectors covered

Pharmaceutical & healthcare Show companies